Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers
Clinical trial NCT05428150 · COMPLETED
Trial details
- NCT number
- NCT05428150
- Sponsor
- Excalibur Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2022-09-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.